Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Trubion Pharmaceuticals, Inc. Reports Second Quarter and First Half 2007 Financial Results
August 31st, 2007
Trubion Pharmaceuticals, Inc. (NASDAQ:TRBN), a biopharmaceutical company developing treatments for autoimmune disease and cancer, announced financial results for its second quarter and six months ended June 30, 2007. Second Quarter and Six Months 2007 Financial Results Revenue for the second quarter and six months ended June 30, 2007 was $5.0 million and $9.8 million respectively, compared to $7.8 million and $13.6 million respectively in 2006. Revenue in the second quarter and first half of 2007 was earned through Trubion's strategic collaboration with Wyeth and consisted of collaborative research funding and amortization of an upfront fee of $40...
Source: Drug Week (2007-08-31)
|
